Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs » Sulfonylureas

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Diabetes Drugs May Reduce Risk for Affective Disorders Posted: Monday, December 10, 2012

Sulfonylureas and metformin may help to reduce the risk for depression.

Sulfonylureas Increase Mortality by 50 Percent Posted: Sunday, July 01, 2012

Data from a large retrospective cohort study suggested that, diabetic patients treated with three commonly prescribed sulfonylurea drugs had a 50% higher mortality risk compared with patients treated with metformin....

Stop Using Sulfonylureas? Posted: Saturday, March 10, 2012

The ACP has issued a clinical practice guideline regarding use of oral agents in type 2 diabetes entitled, "Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline From the American College of Physicians."

Higher Risks of Death and Heart Failure Tied to Sulfonylureas Posted: Sunday, December 13, 2009

Sulfonylurea monotherapy for Type 2 diabetes was associated with increased risks of all-cause death and congestive heart failure compared with metformin, a large, retrospective study showed.

Early Triple Therapy for Type 2 Diabetes Posted: Wednesday, September 23, 2009

When metformin and a sulfonylurea or a glinide fail to bring Type 2 diabetes under control, adding pioglitazone may do the trick, French research suggests.

GLP-1 Liraglutide Versus Sulfonylureas Posted: Wednesday, June 17, 2009

Novo Nordisk experimental diabetes drug liraglutide was significantly better at helping patients control blood sugar than an older common medicine after two years of treatment, according to data from a clinical trial.

Sulphonylurea Drugs Can Have Neuroprotective Effects in Diabetic Patients Posted: Wednesday, March 04, 2009

Hospitalized diabetic stroke patients who receive sulphonylurea therapy appear to be less likely to die and more likely to have a better outcome than patients who do not receive this type of therapy, according to data analyzed from a large patient population that was diagnosed with ischemic stroke.

Combo of Diabetes Drugs Increases Mortality Posted: Thursday, August 21, 2008

Combination treatment for type 2 diabetes using two classes of drugs -- metformin and sulfonylureas -- may increase the risk of hospitalization for cardiovascular disease and mortality, according to a new report.

When Orals Are Not Enough to Control Blood Sugars Posted: Thursday, October 04, 2007

Adding a single analog insulin formulation to metformin and sulfonylurea resulted in current best practice targets of a glycated hemoglobin level of 6.5% or less in fewer than one quarter of patients at 1 year.

Avandia Tied To 43% Increased Heart Attack Risk In Study Posted: Friday, May 25, 2007

Analysis reveals Avandia linked to 43 percent increased risk for heart attack and 64 percent greater risk of cardiovascular death.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.